Related Experiment Video
Updated: Dec 15, 2025
14:46
Dendrimer-based Uneven Nanopatterns to Locally Control Surface Adhesiveness: A Method to Direct Chondrogenic Differentiation
Published on: January 20, 2018
8.1K
Small-Molecule-Functionalized Hyperbranched Polyglycerol Dendrimers for Inhibiting Protein Aggregation
Suman Mandal1, Prasanta Panja1, Koushik Debnath1
1School of Material Sciences, Indian Association for the Cultivation of Science, Kolkata 700032, India.
Biomacromolecules
|July 11, 2020
Summary
Nanoparticle-based small molecules show enhanced performance in preventing amyloid protein aggregation. Functional dendrimers offer a promising nanodrug approach for neurodegenerative diseases.
Area of Science:
- Biochemistry
- Nanotechnology
- Neuroscience
Background:
- Amyloid protein aggregation causes neurodegenerative diseases.
- Small molecules can inhibit protein aggregation but have limitations.
- Nanoparticle formulations can improve drug bioavailability and binding.
Purpose of the Study:
- To synthesize and evaluate functional dendrimers as antiamyloidogenic agents.
- To investigate the efficacy of dendrimers in inhibiting protein aggregation in vitro.
- To explore the potential of dendrimers as nanodrugs for neurodegenerative diseases.
Main Methods:
- Synthesis of hyperbranched polyglycerol dendrimers terminated with gallate, tyrosine, and trehalose.
- Characterization of dendrimer size (∼5 nm) and molecular weight (∼2000 Da).
- Assessment of dendrimer biocompatibility and inhibition of lysozyme/huntingtin protein aggregation.
Main Results:
- Functional dendrimers demonstrated potent antiamyloidogenic activity at micromolar concentrations.
- Trehalose-terminated dendrimers were more effective at inhibiting protein aggregation.
- Gallate-terminated dendrimers showed efficacy in disintegrating mature protein fibrils.
- Dendrimers exhibited high biocompatibility.
Conclusions:
- Functional dendrimers represent a superior approach to small molecules for inhibiting amyloid aggregation.
- Dendrimer-based nanodrugs hold significant potential for treating neurodegenerative diseases.
- Tailoring dendrimer surface modifications can optimize therapeutic outcomes.
